Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
China · Delayed Price · Currency is CNY 6.84
+0.08 (1.18%)
At close: Feb 4, 2026
SHE:002412 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 172.02 | 220.24 | 205.01 | 167.62 | 134.85 | 106.15 |
Depreciation & Amortization | 40.42 | 40.42 | 50.97 | 51.59 | 51.19 | 50.04 |
Other Amortization | 1.07 | 1.07 | 0.72 | 0.71 | 0.71 | 0.7 |
Loss (Gain) From Sale of Assets | - | - | 0.02 | - | - | - |
Asset Writedown & Restructuring Costs | 0.17 | 0.17 | 0.27 | 47.52 | 40.96 | 27 |
Loss (Gain) From Sale of Investments | -12.05 | -12.05 | -62.95 | -92.71 | -68.3 | -53.87 |
Provision & Write-off of Bad Debts | -0.1 | -0.1 | -0.02 | 0.03 | -0.27 | -1.37 |
Other Operating Activities | 72.93 | 1.88 | 6.68 | 3.94 | 7.16 | 7.43 |
Change in Accounts Receivable | -110.32 | -110.32 | -61.77 | -35.83 | 14.34 | 67.43 |
Change in Inventory | 8.18 | 8.18 | 15.23 | -6.93 | -19.57 | 0.7 |
Change in Accounts Payable | -18.55 | -18.55 | 7.56 | 7.93 | 51.92 | -39.31 |
Operating Cash Flow | 153.61 | 130.78 | 160.95 | 143.81 | 212.54 | 163.51 |
Operating Cash Flow Growth | -19.39% | -18.74% | 11.92% | -32.34% | 29.99% | -2.55% |
Capital Expenditures | -17.65 | -11.64 | -19.48 | -11.5 | -229.34 | -129.08 |
Sale of Property, Plant & Equipment | 0.02 | 0 | 0.35 | 0.23 | 0.05 | 0.24 |
Investment in Securities | -51.07 | -38.27 | -64.44 | -96.07 | -48.84 | 9.76 |
Other Investing Activities | 18.21 | 17.71 | 22.01 | 33.85 | 106.49 | 0.5 |
Investing Cash Flow | -60.49 | -42.19 | -65.55 | -84.49 | -172.84 | -118.57 |
Short-Term Debt Issued | - | 84.38 | 105 | 150 | 131.62 | 178 |
Total Debt Issued | 64.38 | 84.38 | 105 | 150 | 131.62 | 178 |
Short-Term Debt Repaid | - | -95 | -130 | -161.62 | -178 | -190.8 |
Total Debt Repaid | -83 | -95 | -130 | -161.62 | -178 | -190.8 |
Net Debt Issued (Repaid) | -18.62 | -10.62 | -25 | -11.62 | -46.38 | -12.8 |
Issuance of Common Stock | - | - | - | 1.35 | - | - |
Common Dividends Paid | -1.95 | -2.55 | -154.67 | -4.07 | -6.58 | -45.38 |
Other Financing Activities | -8.03 | - | - | 0.12 | 0.02 | 0.2 |
Financing Cash Flow | -28.61 | -13.17 | -179.67 | -14.22 | -52.95 | -57.98 |
Net Cash Flow | 64.51 | 75.42 | -84.28 | 45.09 | -13.25 | -13.05 |
Free Cash Flow | 135.95 | 119.15 | 141.47 | 132.3 | -16.8 | 34.42 |
Free Cash Flow Growth | -24.59% | -15.78% | 6.93% | - | - | -73.94% |
Free Cash Flow Margin | 12.93% | 11.86% | 14.80% | 14.44% | -1.88% | 4.64% |
Free Cash Flow Per Share | 0.27 | 0.24 | 0.28 | 0.26 | -0.03 | 0.07 |
Cash Interest Paid | - | - | - | 0.08 | 0.19 | - |
Cash Income Tax Paid | 189.19 | 192.73 | 174.93 | 104.01 | 102.21 | 108.46 |
Levered Free Cash Flow | 69.12 | 39.5 | 81.48 | -25.92 | 49.24 | -46.03 |
Unlevered Free Cash Flow | 70.3 | 41.1 | 83.78 | -23.48 | 53.32 | -41.48 |
Change in Working Capital | -120.84 | -120.84 | -39.75 | -34.89 | 46.24 | 27.42 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.